Vietnam Glycomics Market Report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Vietnam Glycomics Market, valued at USD 10 million, is growing due to biotechnology research, chronic disease prevalence, and national strategies supporting innovation in diagnostics and therapeutics.

Region:Asia

Author(s):Shubham

Product Code:KRAD6786

Pages:89

Published On:December 2025

About the Report

Base Year 2024

Vietnam Glycomics Market Overview

  • The Vietnam Glycomics Market is valued at USD 10 million, based on a five-year historical analysis and benchmarking against the share of Asia–Pacific and global glycomics revenues reported in leading global studies. This growth is primarily driven by advancements in biotechnology, increasing research activities in glycobiology at national institutes and medical universities, and the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders that necessitate innovative diagnostic and therapeutic solutions.
  • Key players in this market are concentrated in major cities such as Ho Chi Minh City and Hanoi. These urban centers dominate due to their robust research infrastructure and concentration of leading academic and research institutions such as the Vietnam Academy of Science and Technology (VAST), Hanoi Medical University, Ho Chi Minh City University of Medicine and Pharmacy, and major hospitals, along with a growing number of biotechnology firms and distributors of global glycomics products that foster innovation and collaboration in glycomics-related research.
  • The Vietnamese government has adopted a series of national biotechnology development strategies that directly support advanced life-science research, including glycomics-related activities. The “National Biotechnology Development Strategy to 2030” issued by the Prime Minister under Decision No. 130/QD?TTg (2021) prioritizes biotechnology for medicine, pharmaceuticals, and diagnostics, with dedicated state budget and public–private investment to strengthen laboratories, promote technology transfer, and support innovative biotech enterprises. In addition, the “National Strategy for the Development of Vietnam’s Pharmaceutical Industry to 2030, with a Vision to 2045” under Decision No. 376/QD?TTg (2021) emphasizes R&D on biologics, vaccines, and high?tech therapies, creating indirect funding and collaboration opportunities for glycomics tools and services.
Vietnam Glycomics Market Size

Vietnam Glycomics Market Segmentation

By Product Type:The product type segmentation includes Enzymes, Kits, Reagents, and Instruments. Enzymes constitute the largest product category in the global glycomics market and similarly represent the leading segment in Vietnam, given their essential role in glycan modification, digestion, and analysis across drug discovery, biomarker research, and biopharmaceutical characterization. The demand for high-quality enzymes is driven by the growing focus on personalized medicine, monoclonal antibody and biologics development, and the need for precise glycan profiling and structural elucidation in both academic and clinical research settings.

Vietnam Glycomics Market segmentation by Product Type.

By Application:The application segmentation encompasses Drug Discovery and Development, Disease Diagnostics, Biopharmaceutical Manufacturing and Quality Control, and Others. Drug Discovery and Development is the leading application area globally and in emerging Asia–Pacific markets, supported by expanding biopharmaceutical pipelines, particularly in monoclonal antibodies, recombinant proteins, and vaccines that require detailed glycan characterization for safety and efficacy. In Vietnam, increasing investment in R&D by pharmaceutical and biotech companies, collaboration between universities and hospitals, and the growing need for novel targeted therapeutics and biosimilars further drive use of glycomics in discovery and preclinical development, while disease diagnostics and biopharmaceutical manufacturing quality control are steadily expanding as testing and bioprocess capabilities mature.

Vietnam Glycomics Market segmentation by Application.

Vietnam Glycomics Market Competitive Landscape

The Vietnam Glycomics Market is characterized by a dynamic mix of regional and international players. Leading participants such as Thermo Fisher Scientific Inc., Merck KGaA (Merck Millipore), Agilent Technologies, Inc., Shimadzu Corporation, Bruker Corporation, New England Biolabs Inc., Promega Corporation, Waters Corporation, Takara Bio Inc., Bio-Techne Corporation, RayBiotech, Inc., Biomedic Scientific & Equipment Co., Ltd. (Biomedic Vietnam), VinBioCare Biotechnology Joint Stock Company, Vietnam Academy of Science and Technology (VAST) – Institute of Biotechnology, Hanoi Medical University – Center for Molecular Biology contribute to innovation, geographic expansion, and service delivery in this space.

Thermo Fisher Scientific Inc.

1956

Waltham, Massachusetts, USA

Merck KGaA (Merck Millipore)

1668

Darmstadt, Germany

Agilent Technologies, Inc.

1999

Santa Clara, California, USA

Shimadzu Corporation

1875

Kyoto, Japan

Bruker Corporation

1960

Billerica, Massachusetts, USA

Company

Establishment Year

Headquarters

Core Role in Value Chain (Supplier, Instrument OEM, Service Provider, End-user)

Estimated Vietnam Glycomics-related Revenue

3-year Revenue CAGR from Glycomics-related Activities

Share of R&D Spend in Glycomics / Total R&D Budget

Number of Active Glycomics-focused Projects or Collaborations in Vietnam

Portfolio Breadth (Enzymes, Kits, Reagents, Instruments, Services)

Vietnam Glycomics Market Industry Analysis

Growth Drivers

  • Increasing Investment in Biotechnology Research:Vietnam's biotechnology sector has seen a significant increase in investment, with funding reaching approximately $600 million in future. This surge is driven by government initiatives aimed at enhancing research capabilities and fostering innovation. The Ministry of Science and Technology has allocated $250 million specifically for biotechnology projects, which includes glycomics research. This financial support is crucial for developing new technologies and therapies, positioning Vietnam as a competitive player in the global glycomics landscape.
  • Rising Prevalence of Chronic Diseases:The World Health Organization reported that chronic diseases account for 75% of all deaths in Vietnam, with diabetes and cardiovascular diseases being the most prevalent. This alarming statistic has prompted a greater focus on research into glycomics, which plays a vital role in understanding disease mechanisms and developing targeted therapies. The increasing healthcare burden is driving demand for innovative solutions, making glycomics research essential for improving patient outcomes and reducing healthcare costs.
  • Growing Demand for Personalized Medicine:The global shift towards personalized medicine is reflected in Vietnam, where the market for tailored therapies is projected to reach $1.2 billion in future. This demand is fueled by advancements in genomics and glycomics, enabling more precise treatment options. As healthcare providers increasingly adopt personalized approaches, the need for glycomics research to identify specific biomarkers and therapeutic targets becomes critical, driving further investment and innovation in the sector.

Market Challenges

  • Limited Awareness and Understanding of Glycomics:Despite the potential of glycomics, there remains a significant knowledge gap among healthcare professionals and the general public in Vietnam. A survey conducted by the Vietnam National University found that only 35% of healthcare providers are familiar with glycomics applications. This lack of awareness hinders the adoption of glycomics-based therapies and slows down research initiatives, ultimately affecting the market's growth potential and innovation.
  • High Costs Associated with Research and Development:The financial burden of conducting glycomics research is substantial, with average R&D costs estimated at $1.8 million per project. This high expenditure poses a significant barrier for many local companies and research institutions, limiting their ability to invest in innovative projects. Additionally, the lengthy timelines associated with R&D in biotechnology further exacerbate the challenge, making it difficult for stakeholders to secure funding and achieve timely results.

Vietnam Glycomics Market Future Outlook

The Vietnam glycomics market is poised for significant advancements, driven by technological innovations and increased collaboration among research institutions. As the government continues to prioritize biotechnology, funding for glycomics research is expected to rise, fostering a more robust ecosystem. Furthermore, the integration of artificial intelligence in research methodologies will enhance data analysis capabilities, leading to more efficient discoveries. These trends indicate a promising future for the glycomics sector, with potential breakthroughs in personalized medicine and therapeutic development on the horizon.

Market Opportunities

  • Collaborations with International Research Institutions:Partnering with global research entities can enhance Vietnam's glycomics capabilities. Such collaborations can facilitate knowledge transfer, access to advanced technologies, and shared funding opportunities, ultimately accelerating research and development efforts in the country.
  • Development of Innovative Glycomics-Based Therapies:There is a significant opportunity to create novel therapies targeting chronic diseases through glycomics research. By focusing on the development of these therapies, Vietnam can address pressing healthcare challenges while positioning itself as a leader in the biotechnology sector, attracting both investment and talent.

Scope of the Report

SegmentSub-Segments
By Product Type

Enzymes

Kits

Reagents

Instruments

By Application

Drug Discovery and Development

Disease Diagnostics

Biopharmaceutical Manufacturing and Quality Control

Others

By End-User

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Contract Research Organizations (CROs)

Hospitals and Clinical Laboratories

By Technology

Mass Spectrometry-based Glycan Analysis

Chromatography-based Glycan Separation

Glycan Microarrays and High-throughput Screening

Nuclear Magnetic Resonance (NMR) Spectroscopy

By Research Type

Basic Glycobiology Research

Translational and Applied Research

Clinical and Biomarker Research

Others

By Funding Source

Government Grants and National Programs

International Donor and Multilateral Funding

Private and Corporate Investments

University and Institutional Research Budgets

By Market Segment

Academic & Public-sector Research

Industrial R&D and Biopharma Production

Clinical and Diagnostic Applications

Contract Services (CROs, CDMOs)

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health, Ministry of Science and Technology)

Biotechnology and Pharmaceutical Companies

Healthcare Providers and Hospitals

Research Institutions and Laboratories

Contract Research Organizations (CROs)

Industry Associations and Trade Organizations

Biomanufacturers and Supply Chain Partners

Players Mentioned in the Report:

Thermo Fisher Scientific Inc.

Merck KGaA (Merck Millipore)

Agilent Technologies, Inc.

Shimadzu Corporation

Bruker Corporation

New England Biolabs Inc.

Promega Corporation

Waters Corporation

Takara Bio Inc.

Bio-Techne Corporation

RayBiotech, Inc.

Biomedic Scientific & Equipment Co., Ltd. (Biomedic Vietnam)

VinBioCare Biotechnology Joint Stock Company

Vietnam Academy of Science and Technology (VAST) Institute of Biotechnology

Hanoi Medical University Center for Molecular Biology

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Vietnam Glycomics Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Vietnam Glycomics Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Vietnam Glycomics Market Analysis

3.1 Growth Drivers

3.1.1 Increasing investment in biotechnology research
3.1.2 Rising prevalence of chronic diseases
3.1.3 Growing demand for personalized medicine
3.1.4 Expansion of healthcare infrastructure

3.2 Market Challenges

3.2.1 Limited awareness and understanding of glycomics
3.2.2 High costs associated with research and development
3.2.3 Regulatory hurdles and compliance issues
3.2.4 Shortage of skilled professionals in the field

3.3 Market Opportunities

3.3.1 Collaborations with international research institutions
3.3.2 Development of innovative glycomics-based therapies
3.3.3 Increasing government support for biotechnology
3.3.4 Expansion into emerging markets

3.4 Market Trends

3.4.1 Advancements in glycomics technologies
3.4.2 Integration of AI in glycomics research
3.4.3 Focus on sustainable and ethical research practices
3.4.4 Growth of public-private partnerships in research

3.5 Government Regulation

3.5.1 Regulatory frameworks for biotechnology products
3.5.2 Guidelines for clinical trials in glycomics
3.5.3 Intellectual property protection laws
3.5.4 Compliance requirements for research funding

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Vietnam Glycomics Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Vietnam Glycomics Market Segmentation

8.1 By Product Type

8.1.1 Enzymes
8.1.2 Kits
8.1.3 Reagents
8.1.4 Instruments

8.2 By Application

8.2.1 Drug Discovery and Development
8.2.2 Disease Diagnostics
8.2.3 Biopharmaceutical Manufacturing and Quality Control
8.2.4 Others

8.3 By End-User

8.3.1 Academic and Research Institutes
8.3.2 Pharmaceutical and Biotechnology Companies
8.3.3 Contract Research Organizations (CROs)
8.3.4 Hospitals and Clinical Laboratories

8.4 By Technology

8.4.1 Mass Spectrometry-based Glycan Analysis
8.4.2 Chromatography-based Glycan Separation
8.4.3 Glycan Microarrays and High-throughput Screening
8.4.4 Nuclear Magnetic Resonance (NMR) Spectroscopy

8.5 By Research Type

8.5.1 Basic Glycobiology Research
8.5.2 Translational and Applied Research
8.5.3 Clinical and Biomarker Research
8.5.4 Others

8.6 By Funding Source

8.6.1 Government Grants and National Programs
8.6.2 International Donor and Multilateral Funding
8.6.3 Private and Corporate Investments
8.6.4 University and Institutional Research Budgets

8.7 By Market Segment

8.7.1 Academic & Public-sector Research
8.7.2 Industrial R&D and Biopharma Production
8.7.3 Clinical and Diagnostic Applications
8.7.4 Contract Services (CROs, CDMOs)

9. Vietnam Glycomics Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Core Role in Value Chain (Supplier, Instrument OEM, Service Provider, End-user)
9.2.3 Estimated Vietnam Glycomics-related Revenue
9.2.4 3-year Revenue CAGR from Glycomics-related Activities
9.2.5 Share of R&D Spend in Glycomics / Total R&D Budget
9.2.6 Number of Active Glycomics-focused Projects or Collaborations in Vietnam
9.2.7 Portfolio Breadth (Enzymes, Kits, Reagents, Instruments, Services)
9.2.8 Presence in Key End-user Segments (Academic, Biopharma, Clinical)
9.2.9 Local Footprint (Labs, Manufacturing, Representative Office, Distributor Network)
9.2.10 Strategic Partnerships with Vietnamese Institutions

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Thermo Fisher Scientific Inc.
9.5.2 Merck KGaA (Merck Millipore)
9.5.3 Agilent Technologies, Inc.
9.5.4 Shimadzu Corporation
9.5.5 Bruker Corporation
9.5.6 New England Biolabs Inc.
9.5.7 Promega Corporation
9.5.8 Waters Corporation
9.5.9 Takara Bio Inc.
9.5.10 Bio-Techne Corporation
9.5.11 RayBiotech, Inc.
9.5.12 Biomedic Scientific & Equipment Co., Ltd. (Biomedic Vietnam)
9.5.13 VinBioCare Biotechnology Joint Stock Company
9.5.14 Vietnam Academy of Science and Technology (VAST) – Institute of Biotechnology
9.5.15 Hanoi Medical University – Center for Molecular Biology

10. Vietnam Glycomics Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health
10.1.2 Ministry of Science and Technology
10.1.3 Ministry of Education and Training
10.1.4 Others

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Pharmaceutical Sector
10.2.2 Research Institutions
10.2.3 Biotechnology Firms
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Pharmaceutical Companies
10.3.2 Research Institutions
10.3.3 Healthcare Providers
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Awareness Levels
10.4.2 Training and Support Needs
10.4.3 Infrastructure Readiness
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Success
10.5.2 Scalability of Solutions
10.5.3 Long-term Benefits
10.5.4 Others

11. Vietnam Glycomics Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity Planning
15.2.2 Milestone Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of published reports from Vietnamese health and biotechnology organizations
  • Review of academic journals focusing on glycomics and its applications in healthcare
  • Examination of government publications and policy documents related to biotechnology and healthcare innovation

Primary Research

  • Interviews with leading researchers and scientists in the field of glycomics
  • Surveys targeting biotechnology firms and research institutions in Vietnam
  • Focus group discussions with healthcare professionals regarding glycomics applications

Validation & Triangulation

  • Cross-validation of findings through multiple data sources including industry reports and expert opinions
  • Triangulation of market trends with insights from academic and industry experts
  • Sanity checks through feedback from a panel of glycomics specialists

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the glycomics market size based on national healthcare expenditure data
  • Segmentation of the market by application areas such as diagnostics, therapeutics, and research
  • Incorporation of growth rates from related biotechnology sectors in Vietnam

Bottom-up Modeling

  • Collection of data on product offerings and sales volumes from key glycomics companies
  • Estimation of market share based on firm-level revenue and growth projections
  • Analysis of pricing strategies and cost structures within the glycomics sector

Forecasting & Scenario Analysis

  • Development of predictive models using historical growth data and market trends
  • Scenario analysis based on potential regulatory changes and technological advancements
  • Creation of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Healthcare Applications of Glycomics100Healthcare Researchers, Clinical Practitioners
Biotechnology Firms in Glycomics80Business Development Managers, R&D Directors
Academic Institutions Focused on Glycomics70Professors, Graduate Researchers
Government Regulatory Bodies50Policy Makers, Regulatory Affairs Specialists
Pharmaceutical Companies Utilizing Glycomics90Product Managers, Clinical Trial Coordinators

Frequently Asked Questions

What is the current value of the Vietnam Glycomics Market?

The Vietnam Glycomics Market is valued at approximately USD 10 million, reflecting a five-year historical analysis and benchmarking against Asia-Pacific and global glycomics revenues. This growth is driven by advancements in biotechnology and increasing research activities in glycobiology.

What are the main drivers of growth in the Vietnam Glycomics Market?

Which cities in Vietnam are key players in the Glycomics Market?

What role does the Vietnamese government play in the Glycomics Market?

Other Regional/Country Reports

Indonesia Glycomics Market

Malaysia Glycomics Market

KSA Glycomics Market

APAC Glycomics Market

SEA Glycomics Market

Thailand Glycomics Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022